(AARD)
NMS – Real Time Price. Currency in USD
3.55
+0.04 (1.14%)
At close: Mar 27, 2026, 4:00 PM EDT
3.62
+0.07 (1.97%)
After-hours: Mar 27, 2026, 7:43 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
3.55
+0.04 (1.14%)
At close: Mar 27, 2026, 4:00 PM EDT
3.62
+0.07 (1.97%)
After-hours: Mar 27, 2026, 7:43 PM EDT
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
| Name | Position |
|---|---|
| Dr. Tien-Li Lee M.D. | CEO, Secretary & Director |
| Date | Type | Document |
|---|---|---|
| 2026-01-12 | 8-K | ck0001774857-20260112.htm |
| 2025-12-10 | 8-K | ck0001774857-20251210.htm |
| 2025-11-13 | 10-Q | ck0001774857-20250930.htm |
| 2025-11-06 | 8-K | ck0001774857-20251105.htm |
| 2025-11-04 | 8-K | ck0001774857-20251104.htm |
| 2025-10-09 | 8-K | ck0001774857-20251008.htm |
| 2025-09-03 | 8-K | ck0001774857-20250902.htm |
| 2025-08-13 | 10-Q | ck0001774857-20250630.htm |
| 2025-08-12 | 8-K | ck0001774857-20250812.htm |
| 2025-05-14 | 10-Q | ck0001774857-20250331.htm |